Art
J-GLOBAL ID：201302210592687312   Reference number：13A0363783

New insights into molecular target therapy for colorectal cancer

大腸癌分子標的療法の新たな知見
Author (6)：
KANEMITSU KIYONORI

About KANEMITSU KIYONORI

(神戸大学大学院食道胃腸外科学)

About 神戸大学大学院食道胃腸外科学

, 
YAMASHITA KIMIHIRO

About YAMASHITA KIMIHIRO

(神戸大学大学院食道胃腸外科学)

About 神戸大学大学院食道胃腸外科学

, 
SUMI YASUO

About SUMI YASUO

(神戸大学大学院食道胃腸外科学)

About 神戸大学大学院食道胃腸外科学

, 
SUZUKI SATOSHI

About SUZUKI SATOSHI

(神戸大学大学院食道胃腸外科学)

About 神戸大学大学院食道胃腸外科学

, 
TANAKA KEN'ICHI

About TANAKA KEN'ICHI

(神戸大学大学院食道胃腸外科学)

About 神戸大学大学院食道胃腸外科学

, 
KAKEJI YOSHIHIRO

About KAKEJI YOSHIHIRO

(神戸大学大学院食道胃腸外科学)

About 神戸大学大学院食道胃腸外科学


Material：
日本消化器病学会雑誌  (Journal of Japanese Society of Gastroenterology)

About 日本消化器病学会雑誌


Volume： 109  Issue： 12  Page： 2021-2030 (J-STAGE)  Publication year： 2012 
JST Material Number： F0892A  ISSN： 0446-6586  CODEN： NIPAA  Document type： Article
Article type： 文献レビュー  Country of issue： Japan (JPN)  Language： JAPANESE (JA)
Thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
human(primates)

About human(primates)

,...
Semi thesaurus term：
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
bevacizumab beyond progression

About bevacizumab beyond progression

,...
Register(free) or Log In to access 

Please login to MyJ-GLOBAL to see full information. You also need to select "Display abstract, etc. of medical articles" in your MyJ-GLOBAL account page in order to see abstracts, etc. of medical articles.

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=13A0363783&from=J-GLOBAL&jstjournalNo=F0892A") }}
JST classification (2)：
JST classification
Category name(code) classified by JST.
Tumors(=neoplasms)of digestive system 
(GH04000D)

About Tumors(=neoplasms)of digestive system

,  Drug therapy(=pharmacotherapy)for tumors 
(GE03032C)

About Drug therapy(=pharmacotherapy)for tumors

Reference (28)：
  • ARNOLD, D. Bevacizumab (BEV) plus chemotherapy (CT) continued beyond first progression in patients with metastatic colorectal cancer (mCRC) previously treated with BEV plus CT : Results of a randomized phase III intergroup study (TML study). J Clin Oncol. 2012, 30, suppl, 3503
  • TOURNIGAND, C. Bevacizumab (Bev) with or without erlotinib as maintenance therapy, following induction first-line chemotherapy plus Bev, in patients (pts) with metastatic colorectal cancer (mCRC) : Efficacy and safety results of the International GERCOR DREAM phase III trial. J Clin Oncol. 2012, 30, suppl, 3500
  • VAN CUTSEM, E. Phase III CORRECT trial of regorafenib in metastatic colorectal cancer (mCRC). J Clin Oncol. 2012, 30, suppl, 3502
  • LONARDI, S. Phase II study of panitumumab (P) in combination with FOLFOXIRI as first-line treatment of metastatic colorectal cancer (mCRC) : Activity in molecularly selected patients (pts). J Clin Oncol. 2012, 30, suppl, 3555
  • 大腸癌研究会. 大腸癌治療ガイドライン医師用2010年. 2010, 26
ｍore...
Terms in the title (2)：
Terms in the title
Keywords automatically extracted from the title.
大腸癌

About 大腸癌

, 
分子標的療法

About 分子標的療法


Return to Previous Page

TOP

BOTTOM